Mimedx (MDXG) Net Income towards Common Stockholders (2016 - 2024)
Historic Net Income towards Common Stockholders for Mimedx (MDXG) over the last 15 years, with Q4 2024 value amounting to $7.4 million.
- Mimedx's Net Income towards Common Stockholders fell 8340.81% to $7.4 million in Q4 2024 from the same period last year, while for Sep 2025 it was $7.4 million, marking a year-over-year decrease of 9063.09%. This contributed to the annual value of $42.0 million for FY2024, which is 2472.94% down from last year.
- According to the latest figures from Q4 2024, Mimedx's Net Income towards Common Stockholders is $7.4 million, which was down 8340.81% from $7.9 million recorded in Q3 2024.
- Mimedx's 5-year Net Income towards Common Stockholders high stood at $44.8 million for Q4 2023, and its period low was -$52.0 million during Q3 2020.
- Its 5-year average for Net Income towards Common Stockholders is -$1.5 million, with a median of -$3.5 million in 2021.
- Per our database at Business Quant, Mimedx's Net Income towards Common Stockholders crashed by 51992.08% in 2020 and then surged by 68183.12% in 2022.
- Mimedx's Net Income towards Common Stockholders (Quarter) stood at -$18.1 million in 2020, then soared by 92.26% to -$1.4 million in 2021, then surged by 681.83% to $8.1 million in 2022, then skyrocketed by 451.13% to $44.8 million in 2023, then plummeted by 83.41% to $7.4 million in 2024.
- Its last three reported values are $7.4 million in Q4 2024, $7.9 million for Q3 2024, and $17.6 million during Q2 2024.